<SEC-DOCUMENT>0000950170-23-015281-index.html : 20230427
<SEC-HEADER>0000950170-23-015281.hdr.sgml : 20230427
<ACCEPTANCE-DATETIME>20230427161351
ACCESSION NUMBER:		0000950170-23-015281
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20230427
DATE AS OF CHANGE:		20230427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amylyx Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001658551
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				464600503
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41199
		FILM NUMBER:		23857036

	BUSINESS ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		617-683-0917

	MAIL ADDRESS:	
		STREET 1:		43 THORNDIKE STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>amlx-defa14a-2023-additi.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: amlx-defa14a-2023-additi.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img43653419_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: img43653419_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img43653419_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: img43653419_1.jpg

</DOCUMENT>
</SEC-DOCUMENT>